Abstract
Nanotechnology is at the frontier of medicine. It plays a critical role in expanding diversity and reach of the drug or drug-like molecules in patients. Nanoparticles act as a protected transport vehicle for hydrophobic drugs or therapeutics such as mRNA, siRNA, and DNA which are normally not bioavailable. In this chapter, we review the different kinds of non-viral nanocarriers that are being employed in modern-day medicine. We also discuss the challenges to effective delivery and function of these particles as well as their application in various aspects of disease treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akinc A, Battaglia G (2013) Cold Spring Harb Perspect Biol 5
Amiji MM, Vyas TK, Shah LK (2009) Discov Med 6:157–162
Aquaro S, Caliò R, Balzarini J, Bellocchi MC, Garaci E, Perno CF (2002) Antiviral Res 55:209–225
Autio KA, Dreicer R, Anderson J, Garcia JA, Alva A, Hart LL, Milowsky MI, Posadas EM, Ryan CJ, Graf RP, Dittamore R, Schreiber NA, Summa JM, Youssoufian H, Morris MJ, Scher HI (2018) JAMA Oncol 4:1344–1351
Babu A, Muralidharan R, Amreddy N, Mehta M, Munshi A, Ramesh R (2016) IEEE Trans Nanobiosci 15:849–863
Barenholz YC (2012) J Controlled Release 160:117–134
Bender AR, Briesen HV, Kreuter J, Duncan IB, Rübsamen-Waigmann H (1996) Antimicrob Agents Chemother 40:1467–1471
Benson ML, Thomson RG, Valli VE (1978) Can J Comp Med 42:368–369
Brown A, Patel S, Ward C, Lorenz A, Ortiz M, DuRoss A, Wieghardt F, Esch A, Otten EG, Heiser LM, Korolchuk VI, Sun C, Sarkar S, Sahay G (2016) Sci Rep 6:31750
Chen Y, Zhu X, Zhang X, Liu B, Huang L (2010) Mol Ther 18:1650–1656
Conner SD, Schmid SL (2003) Nature 422:37–44
De S, Kuwahara S, Saito A (2014) Membranes (Basel) 4:333–355
Diamantis N, Banerji U (2016) Br J Cancer 114:362–367
Doherty GJ, McMahon HT (2009) Annu Rev Biochem 78:857–902
Ducry L, Stump B (2010) Bioconjugate Chem 21:5–13
Eltoukhy AA, Sahay G, Cunningham JM, Anderson DG (2014) ACS Nano 8:7905–7913
Feng C, Wang T, Zhang Y, Qu K, Tang S (2017) Am J Med Sci 354:506–512
Futerman AH, van Meer G (2004) Nat Rev Mol Cell Biol 5:554–565
Garnacho C, Dhami R, Simone E, Dziubla T, Leferovich J, Schuchman EH, Muzykantov V, Muro S (2008) J Pharmacol Exp Ther 325:400–408
Gillespie DL, Aguirre MT, Ravichandran S, Leishman LL, Berrondo C, Gamboa JT, Wang L, King R, Wang X, Tan M, Malamas A, Lu Z-R, Jensen RL (2015) J Neurosurg 122:331–341
Hoff DDV, Mita MM, Ramanathan RK, Weiss GJ, Mita AC, LoRusso PM, Burris HA, Hart LL, Low SC, Parsons DM, Zale SE, Summa JM, Youssoufian H, Sachdev JC (2016) Clin Cancer Res 22:3157–3163
Hsu J, Serrano D, Bhowmick T, Kumar K, Shen Y, Kuo YC, Garnacho C, Muro S (2011) J Control Release 149:323–331
Hsu J, Northrup L, Bhowmick T, Muro S (2012) Nanomedicine 8:731–739
Huang SK, Mayhew E, Gilani S, Lasic DD, Martin FJ, Papahadjopoulos D (1992) Cancer Res 52:6774–6781
Ikonen E (2008) Nat Rev Mol Cell Biol 9:125–138
Kosicek M, Gudelj I, Horvatic A, Jovic T, Vuckovic F, Lauc G, Hecimovic S (2018) Mol Cell Proteomics 17:631–642
Lahtinen U, Honsho M, Parton RG, Simons K, Verkade P (2003) FEBS Lett 538:85–88
Lorusso PM, Edelman MJ, Bever SL, Forman KM, Pilat M, Quinn MF, Li J, Heath EI, Malburg LM, Klein PJ, Leamon CP, Messmann RA, Sausville EA (2012) J Clin Oncol Official J Am Soc Clin Oncol 30:4011–4016
Minelli C, Lowe SB, Stevens MM (2010) Small 6:2336–2357
Minshall RD, Tiruppathi C, Vogel SM, Niles WD, Gilchrist A, Hamm HE, Malik AB (2000) J Cell Biol 150:1057–1070
Muggia FM, Hainsworth JD, Jeffers S, Miller P, Groshen S, Tan M, Roman L, Uziely B, Muderspach L, Garcia A, Burnett A, Greco FA, Morrow CP, Paradiso LJ, Liang LJ (1997) J Clin Oncol 15:987–993
Muro S, Wiewrodt R, Thomas A, Koniaris L, Albelda SM, Muzykantov VR, Koval M (2003) J Cell Sci 116:1599–1609
Muro S, Gajewski C, Koval M, Muzykantov VR (2005) Blood 105:650–658
Nabhan C, Tallman MS (2002) Clin Lymphoma 2(Suppl 1)S19–S23
Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD (1996) J Clin Pharmacol 36:55–63
Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, Schnitzer JE (2007) Nat Biotechnol 25:327–337
Olsen E, Duvic M, Frankel A, Kim Y, Martin A, Vonderheid E, Jegasothy B, Wood G, Gordon M, Heald P, Oseroff A, Pinter-Brown L, Bowen G, Kuzel T, Fivenson D, Foss F, Glode M, Molina A, Knobler E, Stewart S, Cooper K, Stevens S, Craig F, Reuben J, Bacha P, Nichols J (2001) J Clin Oncol Official J Am Soc Clin Oncol 19:376–388
Ramesh R, Saeki T, Smyth Templeton N, Ji L, Stephens LC, Ito I, Wilson DR, Wu Z, Branch CD, Minna JD, Roth JA (2001) Mol Therapy 3:337–350
Ramesh R, Ito I, Saito Y, Wu Z, Mhashikar AM, Wilson DR, Branch CD, Roth JA, Chada S (2004) DNA Cell Biol 23:850–857
Rappaport J, Garnacho C, Muro S (2014) Mol Pharm 11:2887–2895
Sahay G, Alakhova DY, Kabanov AV (2010) J Control Release 145:182–195
Sahay G, Querbes W, Alabi C, Eltoukhy A, Sarkar S, Zurenko C, Karagiannis E, Love K, Chen D, Zoncu R, Buganim Y, Schroeder A, Langer R, Anderson DG (2013) Nat Biotechnol 31:653–658
Sakakibara T, Chen F-A, Kida H, Kunieda K, Cuenca RE, Martin FJ, Bankert RB (1996) Cancer Res 56:3743–3746
Schmid B, Chung D-E, Warnecke A, Fichtner I, Kratz F (2007) Bioconjug Chem 18:702–716
Shah LK, Amiji MM (2006) Pharm Res 23:2638–2645
Stürzl M, Zietz C, Eisenburg B, Goebel F-D, Gillitzer R, Hofschneider PH, Bogner JR (1994) Res Virol 145:261–269
Svenson S, Tomalia DA (2005) Adv Drug Deliv Rev 57:2106–2129
Tai IT, Tang MJ (2008) Drug Resist Updates 11:231–246
Tharkeshwar AK, Trekker J, Vermeire W, Pauwels J, Sannerud R, Priestman DA, Te Vruchte D, Vints K, Baatsen P, Decuypere JP, Lu H, Martin S, Vangheluwe P, Swinnen JV, Lagae L, Impens F, Platt FM, Gevaert K, Annaert W (2017) Sci Rep 7:41408
Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB (1997) J Biol Chem 272:25968–25975
Torchilin VP (2005) Nat Rev Drug Discov 4:145–160
Unezaki S, Maruyama K, Ishida O, Suginaka A, Hosoda J-I, Iwatsuru M (1995) Int J Pharm 126:41–48
Vaage J, Donovan D, Uster P, Working P (1997) Br J Cancer 75:482–486
Vaishnaw AK, Gollob J, Gamba-Vitalo C, Hutabarat R, Sah D, Meyers R, de Fougerolles T, Maraganore J (2010) Silence 1:14
Vanier MT (2010) Orphanet J Rare Dis 5:16
Varkouhi AK, Scholte M, Storm G, Haisma HJ (2011) J Control Release 151:220–228
Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, Pegram M, Oh D-Y, Diéras V, Guardino E, Fang L, Lu MW, Olsen S, Blackwell K, E. S. Group (2012) New Eng J Med 367:1783–1791
Vogel U, Sandvig K, van Deurs B (1998) J Cell Sci 111(Pt 6):825–832
Wang AZ, Gu F, Zhang L, Chan JM, Radovic-Moreno A, Shaikh MR, Farokhzad OC (2008) Expert Opin Biol Ther 8:1063–1070
Younes A, Bartlett NL, Leonard JP, Kennedy DA, Lynch CM, Sievers EL, Forero-Torres A (2010) New Eng J Med 363:1812–1821
Young SWS, Stenzel M, Jia-Lin Y (2016) Crit Rev Oncol/Hematol 98:159–169
Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC (2008) Clin Pharmacol Ther 83:761–769
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mukherjee, A., Bhattacharyya, S. (2020). Nanotechnology in Medicine. In: Saxena, A. (eds) Biotechnology Business - Concept to Delivery. EcoProduction. Springer, Cham. https://doi.org/10.1007/978-3-030-36130-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-36130-3_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-36129-7
Online ISBN: 978-3-030-36130-3
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)